Showing results (141-150 of 158) with videos related to
Sort By:
Pageof 16
Biochemistry|November 25, 2011
Ligand-specific structural changes in the vitamin D receptor in solutionKiran K Singarapu, Jinge Zhu, Marco Tonelli, et al.The Journal of Nutrition|February 4, 2015
Cholecalciferol or 25-hydroxycholecalciferol neither prevents nor treats adenomas in a rat model of familial colon cancerAmy A Irving, Lori A Plum, William J Blaser, et al.European Journal of Medicinal Chemistry|April 14, 2024
Design, synthesis, and biological activity of D-bishomo-1α,25-dihydroxyvitamin D<sub>3</sub> analogs and their crystal structures with the vitamin D nuclear receptorAdrian Fabisiak, Pawel Brzeminski, Rafal R Sicinski, et al.Steroids|December 3, 2011
Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylaseGrazia Chiellini, Simona Rapposelli, Jinge Zhu, et al.Protein Expression and Purification|July 4, 2012
Efficient stable isotope labeling and purification of vitamin D receptor from inclusion bodiesJinge Zhu, Hongyu Rao, Marco Tonelli, et al.American Journal of Nephrology|November 24, 2016
2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized TrialRavi Thadhani, Julia B Zella, Danielle C Knutson, et al.Endocrinology|June 7, 2008
Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammationNancy Liu, Lisa Nguyen, Rene F Chun, et al.Journal of Medicinal Chemistry|August 20, 2008
Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonismMakoto Nakabayashi, Sachiko Yamada, Nobuko Yoshimoto, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 21, 2007
Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidismEduardo Slatopolsky, Jane L Finch, Alex J Brown, et al.Drugs in R&D|September 15, 2017
Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D<sub>3</sub>) in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism on HemodialysisRicha Pandey, Julia B Zella, Jinge G Zhu, et al.Pageof 16